Endurant Capital Management’s Radius Health, Inc. RDUS Stock Holding History

Endurant Capital Management’s Portfolio RDUS Stock Details RDUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-19,100	Closed	-$686K	–	83
2018 Q1	$686K	Sell	19,100 -22,300	-54%	-$806K	0.26%	59
2017 Q4	$1.31M	Buy	41,400 +30,900	+294%	+$970K	0.4%	56
2017 Q3	$405K	Sell	10,500 -12,900	-55%	-$506K	0.12%	82
2017 Q2	$1.06M	Buy	+23,400	New	+$894K	0.3%	66
2016 Q4	–	Sell	-6,300	Closed	-$341K	–	97
2016 Q3	$341K	Sell	6,300 -1,900	-23%	-$96.6K	0.13%	84
2016 Q2	$301K	Buy	+8,200	New	+$290K	0.1%	82

Other funds holding RDUS

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Endurant Capital Management's RDUS Position: Q2 2018 in Review

Endurant Capital Management sold out of Radius Health, Inc. (RDUS) in Q2 2018, closing a stake of 19,100 shares — an estimated $686K sold.

Endurant Capital Management first reported a position in RDUS in Q2 2016 and held it in 6 quarters. The position peaked at $1.31M in Q4 2017. 133 funds tracked by Wall St. Rank hold RDUS as of Q2 2018.

Endurant Capital Management reported no remaining Radius Health, Inc. position as of Q2 2018 after selling out during the quarter.
Endurant Capital Management sold 19,100 Radius Health, Inc. shares in Q2 2018, an estimated $686K.
Endurant Capital Management first reported a position in Radius Health, Inc. in Q2 2016 and held it in 6 quarters.
Endurant Capital Management's Radius Health, Inc. position peaked at $1.31M in Q4 2017.
133 funds tracked by Wall St. Rank held Radius Health, Inc. as of Q2 2018.

Based on Endurant Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.